• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA Grants 510(k) Clearance to LivaNova’s B-Capta

    Gynesonics Appoints Susan Stimson to Its Board of Directors

    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump

    Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

    Abbott Begins Shipping Rapid COVID Self-Tests
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    maxon

    MW Life Sciences

    Qosina Corp.

    K-Tube Technologies

    Creganna Medical, part of TE Connectivity
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS' Engineering Resources Increasingly in Demand

    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    MW Life Sciences

    Trademark Plastics Inc.

    K-Tube Technologies

    Unicep

    Spectrum Plastics Group
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Age of Innovation for Valves

    ...

    Age of Innovation for Valves
    Medtronic's CoreValve Evolut TAVR Platform. Image courtesy of Medtronic.
    Related CONTENT
    • Home Is Where the Heart (Valve) Is
    • Bicuspid Aortic Stenosis Treatment to Create Huge Market Potential for TAVR Devices
    • Edwards Releases 5-Year RESILIA Tissue Aortic Valve Study Data
    • Former Medtronic, St. Jude Executive Assumes CCO Role at JenaValve
    • ACURATE Neo TAVR Valve Fails to Demonstrate Non-Inferiority
    David Novotny, Novella Clinical09.01.17
    By the time one reaches age 75, each of his or her four heart valves will have opened and closed approximately 3 billion times. But aging and illness cause some heart valves to stiffen or flop. Although mild valve damage may be treated with medication such as ACE inhibitors, beta-blockers, or vasodilators to reduce the risk of further damage or to manage symptoms, more significant damage may require repair or a replacement valve.

    As a result of successful innovations in interventional cardiovascular devices, physicians now have many options with which they can repair or replace faulty heart valves.

    The cardiologist and cardiac surgeon will choose either valve repair or replacement based on a number of factors, including the patient’s overall health, the valve itself, and type and severity of the damage.

    Surgical Options
    Surgery is usually selected to address congenital defects in valves, especially for mitral valves. Repairs include opening narrowed or tight valves caused by thickened leaflets; inserting a supportive device that surrounds a leaky valve; reshaping a valve’s leaflet; decalcifying leaflets; repairing the structural support of a valve; or repairing any tears or holes in leaflets.

    When repair is not an option, the valve might be replaced with either a mechanical or bioprosthetic valve. Mechanical valves are made with plastic, carbon, or metal, and are quite sturdy, as they are designed to last for the rest of the patient’s life. Because platelets in the blood often stick to such valves, anticoagulation medication is prescribed to help prevent blood clots.

    Bioprosthetic valves are made from animal tissue and are referred to as xenograft, whereas human tissue from a donated heart is known as an allograft or homograft. If the tissue comes from the patient, it is called an autograft. Tissue-based valves are not as durable as mechanical devices, lasting only about seven to 15 years based on current research and implantation data. But these valves, for the most part, also do not require ongoing anti-coagulants after surgery.

    The Development of TAVR
    One of the most common valve defects is aortic stenosis, or the narrowing of the aortic valve. Globally, about 12.4 percent of people aged 75 and older have aortic stenosis, including 3.4 percent
    with severe aortic stenosis.1 For decades, the standard of care for patients with severe aortic stenosis has been surgical aortic valve replacement. These procedures, however, are not an option for up to 40 percent of patients due to their high surgical risk.

    Less invasive methods to replace valves grew from prototype devices designed to prevent regurgitation in the mid-1960s, culminating with the first use of a balloon aortic valvuloplasty in a human with aortic stenosis in 1985. Researchers built the first artificial valve suitable for percutaneous implantation in the early 1990s and about a decade later, the first transcatheter aortic valve replacement (TAVR) procedure in a human was performed.

    Today, an estimated 100,000 North American and 190,000 European patients annually undergo the procedure.2 Commercial sales for TAVR devices is anticipated to reach nearly $4 billion by 2020.3

    A Dynamic Market Meets Evolving Challenges
    The success of TAVR has created an opportunity for advancing transcatheter approaches for patients in need of mitral valve replacement. Several companies are developing transcatheter mitral valve repair (TMVR) devices, with the first receiving U.S. Food and Drug Administration approval in 2013. The pace of TMVR clinical trials has not yet matched that of TAVR due to the complex structure of mitral valves and the need for devices to serve a larger patient population with more diverse conditions and comorbidities.

    Along with testing new TAVR and TMVR devices and procedures, sponsors are examining existing devices in new patient populations in an effort to improve surgical precision and safety, enhance patient outcomes, and boost device durability. Actually, durability and its implications for device use in lower-risk populations has been of keen interest in the last two years, during the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). 

    Last year, one study suggested TAVR may not be suitable for younger patients and those at lower risk.4 Though it was a small study and examined only three first-generation devices, investigators found moderate to severe degeneration in 35 of 100 patients who survived at least five years after their procedures. The percentage of patients without deterioration decreased from about 80 at year six to less than 40 by year eight. Just two of 387 patients survived 10 years after the intervention.

    Experts noted the results may not apply to newer devices, which are evolving in strength and design, but caution may be appropriate in considering TAVR for lower risk populations.5

    Despite progress addressing new frontiers, old challenges remain to be conquered and offer new strategic opportunities for success to manufacturers and ultimately, the patient. The cardiovascular device space still needs to account for the variability in each patient’s valve structure, health, and complex positioning and anchoring needs. Trials will need to examine how any investigational device, particularly TMVR devices, prevents obstructions and perivalvular leaks while collecting data that shows valve repair or replacement prolongs patient survival and improves quality of life. 

    References
    1. Osnabrugge, R., et al. Disease Prevalence and Number of Candidates for Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2013;62(11):1002-1012.
    2. Bourantas, C. and Serruys P. Evolution of Transcatheter Aortic Valve Replacement. Circulation Research. 2014; 114: 1037-1051 doi: 10.1161/CIRCRESAHA.114.302292. bit.ly/mpo091701
    3. Technavio. Global Transcatheter Aortic Valve Replacement Market to Generate Close to USD 4 Billion by 2020, says Technavio. Press release. Feb. 3, 2016.
    4. Lou, N. “EuroPCR: Degenerated TAVR Not Uncommon by 10 Years.” MedPage Today. May 17, 2016. bit.ly/mpo091702
    5. Dvir, D. First look at long-term durability of transcatheter heart valves: assessment of valve function up to 10 years after implantation. Presented at: EuroPCR 2016. May 17, 2016. Paris, France. bit.ly/mpo091703


    David Novotny is senior vice president of Novella Clinical’s Medical Device & Diagnostics Division, overseeing the Cardiovascular Therapies delivery unit. He has nearly 20 years of clinical research experience in the hospital, clinical research organization, medical device, and biopharmaceutical environments. Novotny is responsible for the oversight, strategy, and operational success of all medical device and diagnostics sponsor programs globally at Novella, including clinical execution and governance management.
    Related Searches
    • durability
    • quality
    • evolution
    • president
    Related Knowledge Center
    • Surgical
    • Cardiovascular
    Suggested For You
    Home Is Where the Heart (Valve) Is Home Is Where the Heart (Valve) Is
    Bicuspid Aortic Stenosis Treatment to Create Huge Market Potential for TAVR Devices Bicuspid Aortic Stenosis Treatment to Create Huge Market Potential for TAVR Devices
    Edwards Releases 5-Year RESILIA Tissue Aortic Valve Study Data Edwards Releases 5-Year RESILIA Tissue Aortic Valve Study Data
    Former Medtronic, St. Jude Executive Assumes CCO Role at JenaValve Former Medtronic, St. Jude Executive Assumes CCO Role at JenaValve
    ACURATE Neo TAVR Valve Fails to Demonstrate Non-Inferiority ACURATE Neo TAVR Valve Fails to Demonstrate Non-Inferiority
    Medtronic Begins TAVR Study Comparing Evolut Against Edwards Medtronic Begins TAVR Study Comparing Evolut Against Edwards' Sapien Valve
    LivaNova Launches Perceval Plus Aortic Heart Valve in Europe LivaNova Launches Perceval Plus Aortic Heart Valve in Europe
    Medtronic to Begin Feasibility Study of Intrepid TTVR in Heart Valve Disease Medtronic to Begin Feasibility Study of Intrepid TTVR in Heart Valve Disease
    Heart Valve Innovator Foldax Closes $20 Million Financing Heart Valve Innovator Foldax Closes $20 Million Financing
    Polymeric Heart Valve Could Prevent Need for Lifelong Blood Thinners Polymeric Heart Valve Could Prevent Need for Lifelong Blood Thinners
    Medtronic Releases Evolut Low Risk Bicuspid Study Results Medtronic Releases Evolut Low Risk Bicuspid Study Results
    FDA Warns US Stem Cell Clinic of Significant Deviations FDA Warns US Stem Cell Clinic of Significant Deviations
    An Examination of User Fees’ Impact on Review Times An Examination of User Fees’ Impact on Review Times
    Medtech Must Heed Choice-of-Law and Choice-of-Forum Clauses Medtech Must Heed Choice-of-Law and Choice-of-Forum Clauses
    Medtronic Medtronic's Attain Stability Quad Active-Fixation Heart Lead Gains CE Mark

    Related Columns

    • Cardiovascular | Surgical
      Home Is Where the Heart (Valve) Is

      Home Is Where the Heart (Valve) Is

      Artificial heart valve makers reached a number of milestones despite the pandemic’s global squeeze.
      Sam Brusco, Associate Editor 04.01.21

    • Surgical
      Biomechanical Engineer, Heal Thyself

      Biomechanical Engineer, Heal Thyself

      Choosing a treatment option for spinal disorders can be tricky with extensive knowledge of the industry.
      Dawn A. Lissy, Founder & President, Empirical 04.01.21

    • Molding | Surgical
      Optimizing MIM in Medical Device Manufacturing

      Optimizing MIM in Medical Device Manufacturing

      Metal injection molding (MIM) is a good choice for producing medium- to high-volume medtech parts.
      Steve Santoro, Executive Vice President, MICRO 04.01.21


    • Surgical
      Rethink Your Medtech ASC Strategy, Part 1

      Rethink Your Medtech ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.03.21

    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Surgical
      Hype or Hope? The Future of Surgical Robotics

      Hype or Hope? The Future of Surgical Robotics

      Recent publications suggest the U.S. performs more robotic surgery than every other country in the world.
      Maria Shepherd, President and Founder, Medi-Vantage 10.01.20


    • R&D & Design | Surgical
      Sparking Innovation as We Struggle to Find the New Normal

      Sparking Innovation as We Struggle to Find the New Normal

      The goal is to find the best ideas to support orthopedic patients adjusting to additional pain and immobility while they wait for elective surgeries.
      Dawn A. Lissy, Founder & President, Empirical 06.04.20

    • Surgical
      Safely Opening Up Medtech in a COVID-19 World

      Safely Opening Up Medtech in a COVID-19 World

      While it was important to suspend elective procedures in March, the industry has yet to comprehend the ramifications of the shutdown.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 06.04.20

    • Cardiovascular
      The TAVR Plot Thickens

      The TAVR Plot Thickens

      Transcatheter aortic valve replacement (TAVR) surgery has typically targeted patients considered too risky to undergo open-heart surgery.
      Sam Brusco, Associate Editor 09.06.19


    • Cardiovascular | Diagnostics | Digital Health | Patient Monitoring
      Cardiac Care on the Can

      Cardiac Care on the Can

      ...
      Sam Brusco, Associate Editor 04.03.19

    • Cardiovascular
      What’s New with TAVR?

      What’s New with TAVR?

      ...
      Maria Shepherd, President and Founder, Medi-Vantage 04.03.19

    • Surgical
      Premium Medtech Price Strategies for the Robotics Segment

      Premium Medtech Price Strategies for the Robotics Segment

      ...
      Maria Shepherd, President and Founder, Medi-Vantage 09.07.18


    • Cardiovascular
      15 Years of Consi-stent Medtech Progress

      15 Years of Consi-stent Medtech Progress

      ...
      Sam Brusco, Associate Editor 06.04.18

    • 3D/Additive Manufacturing | Surgical
      Top 5 of the Past 15: Moments that Shifted, Shaped, or Shook the Medical Device Industry

      Top 5 of the Past 15: Moments that Shifted, Shaped, or Shook the Medical Device Industry

      ...
      Dawn A. Lissy, President & Founder, Empirical 06.04.18

    • Cardiovascular | Digital Health | Neurological
      The Human Cyborg, Circa 2033

      The Human Cyborg, Circa 2033

      ...
      Michael Barbella, Managing Editor 06.04.18


    Trending
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Harnessing Critical Health Data With Wearable Technology
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    • Gynesonics Appoints Susan Stimson to Its Board of Directors
    • Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    • Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology
    • Abbott Begins Shipping Rapid COVID Self-Tests
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Longvida Curcumin Extract Receives ANVISA Approval in Brazil
    Curcugen Curcumin Formulation Evidenced to Attenuate Post-Exercise Inflammation
    Good Rāz Launches Taste-Free Vitamin D3 Drops
    Coatings World

    Latest Breaking News From Coatings World

    USGBC Releases Results of 2021 Green Building Community Survey
    PPG Publishes Sustainability Report
    Sherwin-Williams Launches Echelon
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    Gynesonics Appoints Susan Stimson to Its Board of Directors
    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Evotec to Build Second Biologics Mfg. Facility in Toulouse
    Adare Pharma Names Ludger Roedder President of Adare Biome
    Johnson & Johnson 1Q Results
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Donginbi Launches Men’s Skincare Collection
    Kiehl’s Launches Pouch Refillables
    Skin Match Technology Partners with Men-Only Grooming Platforms
    Happi

    Latest Breaking News From Happi

    Robertet Appoints Reichert as Perfumer
    Kiehl’s Launches Sustainable Pouch Refillables for Hair Care, Skin Care
    New OTC Natural Hemp Pain Relief Gel Arrives at cbdMD
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PPG releases 2020 Sustainability Report
    GAA merges with AIMCAL
    Acucote expands Insights educational program
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Glatfelter GlatClean Nominated for World of Wipes Innovation Award
    P&G’s Sales Up 5%
    Ontex Tests Industrial Scale Diaper Composting
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Spinal Elements' Lucent 3D Additive Manufactured Interbodies Earn FDA Nod
    Conformis, Paragon 28 Ink Licensing Deal
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints imec, Soitec Executives to Europe Advisory Board
    NREL Takes Novel Approach to 3D-Printed Water Power Prototypes
    Canatu Manufactures World’s Thinnest Free-standing CNB Membrane

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login